Selective killing of osteosarcoma cells by adenovirus-mediated transfer of vascular endothelial growth factor promoter-thymidine kinase gene in vitro

周正明,殷正丰,王孟龙,吴宗娣,康晓燕,杨惠光,吴孟超

DOI: https://doi.org/10.3781/j.issn.1000-7431.2004.01.017

2004-01-01

Tumori

Abstract:Objective The purpose of this study was to investigate whether herpes simplex virus thymidine kinase (HSV-tk) gene expression driven by VEGF promoter followed by ganciclovir (GCV) administration would be effective in killing osteosarcoma cells in vitro. Methods Recombinant adenoviral vectors were constructed with HSV-tk under the control of VEGF promoter(AdVEGF-tk) or cytomegalovirus (CMV) promoter (AdCMV-tk). AdVEGF-tk and AdCMV-tk were transduced into osteoblastic cell line MC3T3-E1 with lower expression of VEGF and osteosarcoma cell line LM8 with higher expression of VEGF, followed by GCV treatment for 5 days. The sensitivity to GCV of infected cells was measured with MTT method. Results GCV did not inhibit the growth of both cell lines tested, but significantly inhibit the growth of both cell lines infected with AdCMV-tk. Lower cytotoxicity of GCV was observed in AdVEGF-tk infected MC3T3-E1 cell, 30% were killed at GCV concentration of 50 μg/ml. On the contrary, higher cytotoxicity of GCV was observed in AdVEGF-tk infected LM8 cell, 95% were killed at GCV concentration of 50 μg/ml. Conclusion Adenoviral vector containing VEGF promoter for the HSV-tk plus GCV treatment appears to be highly selective in killing osteosarcoma cell line in vitro.